Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation Cannabis Investing News
Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa Medical Device Investing
Merck Announces Phase 3 KEYNOTE-522 Trial Met Dual Primary Endpoint of Event-Free Survival in Patients With High-Risk Early-Stage Triple-Negative Breast Cancer Video Interview
Knight to Present at the 2021 RBC Capital Markets Global Healthcare Conference Medical Device Investing
BLU, NEPT & ROOT Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Biotech Investing
FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BELLUS Health Inc. Investors with Large Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
Bristol Myers Squibb Presents New Research at ASCO and EHA 2021 Featuring Novel Approaches and Demonstrating Significant Progress to Improve Survival in Cancer and Blood Disorders Biotech Investing
DEADLINE ALERT for NEPT, BLU, ACAD, PINS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders Biotech Investing
MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
Deadline of May 17, 2021 for BELLUS Health Inc. Class Action - Bronstein, Gewirtz & Grossman, LLC Encourages Investors With Losses Exceeding $200K to Actively Participate Biotech Investing
